Dimensional Fund Advisors LP Reduces Holdings in Encompass Health Co. (NYSE:EHC)

Dimensional Fund Advisors LP trimmed its stake in shares of Encompass Health Co. (NYSE:EHC) by 0.1% during the second quarter, HoldingsChannel.com reports. The firm owned 1,010,795 shares of the company’s stock after selling 1,507 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Encompass Health were worth $78,876,000 as of its most recent filing with the SEC.

Several other large investors also recently added to or reduced their stakes in the stock. Principal Financial Group Inc. increased its stake in Encompass Health by 9.9% in the 1st quarter. Principal Financial Group Inc. now owns 780,559 shares of the company’s stock worth $63,928,000 after acquiring an additional 70,509 shares during the last quarter. Pendal Group Limited increased its stake in Encompass Health by 24.6% in the 1st quarter. Pendal Group Limited now owns 4,001 shares of the company’s stock worth $328,000 after acquiring an additional 791 shares during the last quarter. Schroder Investment Management Group increased its stake in Encompass Health by 12.9% in the 1st quarter. Schroder Investment Management Group now owns 1,251,115 shares of the company’s stock worth $102,467,000 after acquiring an additional 142,797 shares during the last quarter. Warren Averett Asset Management LLC bought a new position in Encompass Health in the 1st quarter worth about $391,000. Finally, Invst LLC bought a new position in Encompass Health in the 1st quarter worth about $480,000. Institutional investors own 90.64% of the company’s stock.

Shares of EHC stock opened at $67.05 on Thursday. The stock has a market capitalization of $6.67 billion, a PE ratio of 17.46, a P/E/G ratio of 0.99 and a beta of 1.10. Encompass Health Co. has a 1-year low of $60.51 and a 1-year high of $89.68. The business has a 50-day moving average of $74.61 and a 200 day moving average of $78.03. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.07 and a quick ratio of 1.07.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, July 26th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $0.98 by $0.19. Encompass Health had a return on equity of 19.49% and a net margin of 7.83%. The business had revenue of $1.29 billion during the quarter, compared to analysts’ expectations of $1.28 billion. During the same quarter last year, the business posted $0.34 EPS. The business’s revenue was up 22.9% on a year-over-year basis. Analysts anticipate that Encompass Health Co. will post 4.43 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 15th. Stockholders of record on Friday, October 1st will be given a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.67%. The ex-dividend date is Thursday, September 30th. Encompass Health’s dividend payout ratio is currently 38.75%.

EHC has been the topic of a number of research analyst reports. Truist decreased their target price on Encompass Health from $100.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday. UBS Group began coverage on Encompass Health in a research note on Thursday, September 23rd. They issued a “buy” rating and a $98.00 target price on the stock. Credit Suisse Group increased their price objective on Encompass Health from $96.00 to $98.00 and gave the company an “outperform” rating in a research report on Thursday, July 29th. Raymond James upgraded Encompass Health from an “outperform” rating to a “strong-buy” rating and increased their price objective for the company from $95.00 to $107.00 in a research report on Monday, August 2nd. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Encompass Health from $104.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, July 29th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $96.70.

Encompass Health Company Profile

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.

Recommended Story: Growth Stocks

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.